| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/19/1993 | CA2074020A1 Trifluormethylbenzylphosphonates useful in treating osteoporosis |
| 01/19/1993 | CA1312872C Vitamin a preparation process |
| 01/19/1993 | CA1312871C Indene and naphthalene derivatives |
| 01/19/1993 | CA1312870C Alkanesulfonamides as antiglaucoma agents |
| 01/19/1993 | CA1312869C Pyridine derivatives |
| 01/19/1993 | CA1312866C Benzo¬b|pyranes and pyranopyridines, process for their production and their use |
| 01/19/1993 | CA1312864C Tricyclic derivatives which are agonists of cholinergic receptors, and drugs in which they are present |
| 01/19/1993 | CA1312863C Carbamic acid esters of benzazepines |
| 01/19/1993 | CA1312862C Erythromycin derivative and process for preparing the same |
| 01/19/1993 | CA1312861C Heparin derivatives and low molecular weight heparin derivatives |
| 01/19/1993 | CA1312860C Process for preparation of aloe products |
| 01/19/1993 | CA1312858C 3-deoxy mycaminosyl tylonolide derivatives |
| 01/19/1993 | CA1312856C 6,16-dimethyl corticoids, their preparation and use |
| 01/19/1993 | CA1312826C Gepirone for alleviation of panic disorders |
| 01/19/1993 | CA1312825C Prevention or interruption of panic states with an imidazobenzodiazepine |
| 01/19/1993 | CA1312824C Freeze-dried pharmaceutical compositions of phenylquinoline carboxylic acids |
| 01/18/1993 | CA2074038A1 Decahydro-8h-isoquino[2,1-g][1,6]naphthyridine and decahydrobenzo[a] pyrrol[2,3-e]quinolizine derivatives |
| 01/18/1993 | CA2070492A1 Acetohydroxamic acid compound, pharmaceutical compositions containing this compound and processes for the preparation of this compound and these compositions |
| 01/16/1993 | CA2073643A1 3,4-dehydropiperidine derivatives |
| 01/14/1993 | DE4123587A1 2,14-disubstituierte ergoline, deren herstellung und verwendung in arzneimitteln 2,14-disubstituted ergoline, their production and use in medicinal products |
| 01/14/1993 | DE4123001A1 Pharmazeutische zusammensetzung fuer die peritonealdialyse A pharmaceutical composition for peritoneal dialysis |
| 01/14/1993 | DE4122999A1 Metabolisierbarer plasmaersatz Metabolizable plasma substitute |
| 01/14/1993 | DE4122337A1 Stable 5-amino-salicylic acid enema suspensions |
| 01/14/1993 | DE4121468A1 New use of cpds. isolated from Streptomyces - for treatment of HIV infection |
| 01/13/1993 | WO1993001185A1 2,14-disubstituted ergolines, their production and use in medicaments |
| 01/13/1993 | WO1993000901A1 Pharmaceutical compositions |
| 01/13/1993 | EP0523013A2 Use of benzimidazoline-2-oxo-1-carboxylic acid derivatives in the treatment of organic mental diseases |
| 01/13/1993 | EP0522972A1 Process for preparation of a dextrorotatory isomer of an isoindolinone derivative |
| 01/13/1993 | EP0522971A1 Dextrorotatory isomer of a derivative of 2-amino naphthyridine and its preparation |
| 01/13/1993 | EP0522970A1 Process for the preparation of optical isomers of a 2-aminonaphthyridine derivative |
| 01/13/1993 | EP0522969A1 2-Aminonaphthyridine, its preparation and use |
| 01/13/1993 | EP0522964A1 Compositions to arrest hair loss and to induce and stimulate hair growth based on 2,4-diamino-pyrimidin-3-oxide derivatives |
| 01/13/1993 | EP0522944A2 Use of 3-(3-pyridinyl)-1H,3H-pyrrolo(1,2-c)thiazole-7-carboxamide for the treatment of retroviral infections |
| 01/13/1993 | EP0522937A1 Taxane derivatives containing compositions |
| 01/13/1993 | EP0522936A1 Taxane derivatives containing compositions |
| 01/13/1993 | EP0522915A1 Pyrimidine-4-carboxamide derivatives, their preparation and their use in therapeutics |
| 01/13/1993 | EP0522914A1 2-Piperidinylpyrimidin-4-carboxamide derivatives, their preparation and their application in therapy |
| 01/13/1993 | EP0522808A2 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
| 01/13/1993 | EP0522715A1 Squalene synthethase inhibitors and processes therefrom |
| 01/13/1993 | EP0522599A1 New method for the isolation of castanospermine |
| 01/13/1993 | EP0522576A2 Aminoethane-1,1-bisphosphonic acids and aminoethane-1,1-alkylphospinic/phosphonic acids, process of their preparation and their use |
| 01/13/1993 | EP0522504A1 2-(2-substituted pyrrolidinylthio)-carbapenem derivatives |
| 01/13/1993 | EP0522502A1 Inhibitors of sucrase activity from tea |
| 01/13/1993 | EP0522494A1 Novel isatineoxime derivatives, their preparation and use |
| 01/13/1993 | EP0522433A1 Oral aqueous solutions containing ubidecarenone |
| 01/13/1993 | EP0522431A1 Phophorus-containing HMG-COA reductase inhibitors |
| 01/13/1993 | EP0522277A1 Process for the preparation of 9-fluoro-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzothiazine-6-carboxylic acid hydrochloride |
| 01/13/1993 | EP0522226A1 Eyedrop solution for the treatment of ocular hypertension containing ketauserin |
| 01/13/1993 | EP0522176A1 Dihydropyridine compounds, and process for their preparation |
| 01/13/1993 | EP0522173A1 4-desoxy-4-epipodophyllotoxin derivative or pharmaceutically acceptable salt thereof |
| 01/13/1993 | EP0522122A1 Pharmaceutical compositions containing amethocaine |
| 01/13/1993 | EP0522084A1 Antiviral compositions and method for their use |
| 01/13/1993 | EP0522078A1 Gp75 as a tumor vaccine for melanoma |
| 01/13/1993 | EP0522038A1 Substituted pyrimidines, pyrimidinones and pyridopyrimidines |
| 01/13/1993 | EP0522006A1 Compositions comprising cytotoxic agent and permeation enhancers |
| 01/13/1993 | EP0522004A1 Use of copper(ii) containing compounds to accelerate wound healing |
| 01/13/1993 | EP0522000A1 5-lipoxygenase inhibitors |
| 01/13/1993 | EP0521986A1 Topically active ocular gem-diacylthiadiazole sulfonamide carbonic anhydrase inhibitors |
| 01/13/1993 | EP0521974A1 Veterinary treatment. |
| 01/13/1993 | EP0521936A1 Unsaturated n-benzoxodiazopyranyl lactams, their production and use |
| 01/13/1993 | EP0521887A1 Cephalosporins, process for their preparation and pharmaceutical compositions containing them |
| 01/13/1993 | EP0521871A1 Alternative enzyme substrates as deodorants |
| 01/13/1993 | EP0329708B1 Liquid calcium supplementation from readily soluble mixtures of calcium compound and citric acid |
| 01/13/1993 | EP0275249B1 Continuous intravenous infusion of adenosine to human patients, a unit dosage form of adenosine and use of adenosine for the manufacture of medicaments |
| 01/13/1993 | EP0271581B1 Novel compounds dc-88a and dc-89a1 and process for their preparation |
| 01/13/1993 | CN1067921A Antibiotic compound |
| 01/13/1993 | CN1067894A One-seep sublimer for extracting natural caffeine from tea |
| 01/13/1993 | CN1067893A Heterocyclic derivatives |
| 01/13/1993 | CN1067892A Process for preparing pyrrolo ( 2,3-b) pyridine derivatives |
| 01/13/1993 | CN1067890A Heterocyclic compounds, their production and use |
| 01/13/1993 | CN1067889A Manufacture process for substituted n-(1-alkyl-3-hydroxy-4-piperidinyl) benzamides |
| 01/13/1993 | CN1067888A Derivatives of 2-piperidylpyrimidine-4-carboxamide, its preparation and its application in therapeutics |
| 01/13/1993 | CN1067887A Derivative of 2-aminapyrimidine-4-carboxamide, its preparation and application in therapy |
| 01/13/1993 | CN1067886A New urea derivatives, processes for preparation thereof and pharmaceutical composition comprising same |
| 01/13/1993 | CN1067885A Derivative of 2-aminopyrimidine-4-carboxamide, its preparation and application in therapy |
| 01/13/1993 | CN1067884A Derives of pyrimidine-4-carboxamide, their preparation and their application in therapeutics |
| 01/13/1993 | CN1067883A 纤维蛋白原受体拮抗剂 Fibrinogen receptor antagonists |
| 01/13/1993 | CN1067881A Synthesizing technology of " puyantong" |
| 01/13/1993 | CN1067811A Transdermal nicotine absorption dosage unit and process |
| 01/13/1993 | CN1067809A Oral presentation forms for acid-unstable active compounds |
| 01/13/1993 | CA2091455A1 2,14-disubstituted ergolines, their production and use in medicaments |
| 01/13/1993 | CA2091251A1 Pharmaceutical compositions |
| 01/13/1993 | CA2072726A1 Anti-glaucoma compositions |
| 01/12/1993 | US5179216 Anticholesterol agents and atherosclerosis |
| 01/12/1993 | US5179206 Substituted 3-aminosydnone imines |
| 01/12/1993 | US5179190 Supramolecular surfactants: amphiphilic polymers designed to disrupt lipid membranes |
| 01/12/1993 | US5179126 Administering drug selected from the group of fluvoxamine and sertraline |
| 01/12/1993 | US5179124 Anti-inflammatory for use in external and internal eye inflammations |
| 01/12/1993 | US5179122 Nutritional supplement containing vitamin e |
| 01/12/1993 | US5179120 Porphycene compounds for photodynamic therapy |
| 01/12/1993 | US5179118 Indazolanonyl derivatives of benzopyrans |
| 01/12/1993 | US5179115 Bicyclic heterocyclic derivatives as 5-lipoxygenase inhibitors |
| 01/12/1993 | US5179113 Treatment of central nervous disorders with imidazole compounds |
| 01/12/1993 | US5179111 Anxiolytic agents |
| 01/12/1993 | US5179110 Adrenergic stimulants; antiulcer agents, bronchodilators, treatment of diarrhea, glaucoma, osteoporisis, prostate, diabetes, migraine |
| 01/12/1993 | US5179109 Pharmaceutical compositions for neuroprotection containing arylcyclohexylamines |
| 01/12/1993 | US5179108 Derivatives of 4-(aminomethyl) piperidine, their preparation and their therapeutic application |
| 01/12/1993 | US5179106 Enzyme inhibitors; respiratory system disorders |
| 01/12/1993 | US5179104 Multistage process for forming viricides |
| 01/12/1993 | US5179100 4,5-dihydropyrazolo[3,4-a]acridines |